Global Pulmonary Drugs Market Study 2015-2025, by Segment (Inhaled Corticosteroids (ICS), Long-Acting Beta2-Agonists (LABA), Antihistamine), by Market (Asthma & COPD, Allergic Rhinitis, Pulmonary Arterial Hypertension), by Company (AstraZeneca plc, Bayer AG, Teva Pharmaceutical Industries Ltd)

November 2018 | 63 pages | ID: GED0CC6456CEN
99Strategy

Abstracts

Snapshot

The global Pulmonary Drugs market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

• Inhaled Corticosteroids (ICS)
• Long-Acting Beta2-Agonists (LABA)
• Antihistamine
• Vasodilators
• Short-Acting Beta2-Agonists (SABA)
• Anticholinergics
• Combination Drugs
• MAbs
• Enzymes
• Antibiotics & Antileukotrienes

Demand Coverage (Market Size & Forecast, Consumer Distribution):

• Asthma & COPD
• Allergic Rhinitis
• Pulmonary Arterial Hypertension
• Cystic Fibrosis

Company Coverage (Sales data, Main Products & Services etc.):

• AstraZeneca plc
• Bayer AG
• Teva Pharmaceutical Industries Ltd
• Actelion Pharmaceuticals, Inc.
• Boehringer Ingelheim GmbH
• F. Hoffmann-La Roche Ltd.
• Merck & Co., Inc.
• Novartis AG
• GlaxoSmithKline plc
• Sunovion Pharmaceuticals

Major Region Market

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Contents

1 INDUSTRY OVERVIEW

1.1 Pulmonary Drugs Industry
  1.1.1 Overview
  1.1.2 Products of Major Companies
1.2 Market Segment
  1.2.1 Industry Chain
  1.2.2 Consumer Distribution
1.3 Price & Cost Overview

2 PULMONARY DRUGS MARKET BY TYPE

2.1 By Type
  2.1.1 Inhaled Corticosteroids (ICS)
  2.1.2 Long-Acting Beta2-Agonists (LABA)
  2.1.3 Antihistamine
  2.1.4 Vasodilators
  2.1.5 Short-Acting Beta2-Agonists (SABA)
  2.1.6 Anticholinergics
  2.1.7 Combination Drugs
  2.1.8 MAbs
  2.1.9 Enzymes
  2.1.10 Antibiotics & Antileukotrienes
2.2 Market Size by Type
2.3 Market Forecast by Type

3 GLOBAL MARKET DEMAND

3.1 Segment Overview
  3.1.1 Asthma & COPD
  3.1.2 Allergic Rhinitis
  3.1.3 Pulmonary Arterial Hypertension
  3.1.4 Cystic Fibrosis
3.2 Market Size by Demand
3.3 Market Forecast by Demand

4 MAJOR REGION MARKET

4.1 Global Market Overview
  4.1.1 Market Size & Growth
  4.1.2 Market Forecast
4.2 Major Region
  4.2.1 Market Size & Growth
  4.2.2 Market Forecast

5 MAJOR COMPANIES LIST

5.1 AstraZeneca plc (Company Profile, Sales Data etc.)
5.2 Bayer AG (Company Profile, Sales Data etc.)
5.3 Teva Pharmaceutical Industries Ltd (Company Profile, Sales Data etc.)
5.4 Actelion Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
5.5 Boehringer Ingelheim GmbH (Company Profile, Sales Data etc.)
5.6 F. Hoffmann-La Roche Ltd. (Company Profile, Sales Data etc.)
5.7 Merck & Co., Inc. (Company Profile, Sales Data etc.)
5.8 Novartis AG (Company Profile, Sales Data etc.)
5.9 GlaxoSmithKline plc (Company Profile, Sales Data etc.)
5.10 Sunovion Pharmaceuticals (Company Profile, Sales Data etc.)

6 CONCLUSION

List Of Tables

LIST OF TABLES

Table GLOBAL PULMONARY DRUGS MARKET 2015-2018, BY TYPE, IN USD MILLION
Table Global Pulmonary Drugs Market 2015-2018, by Type, in Volume
Table Global Pulmonary Drugs Market Forecast 2019-2025, by Type, in USD Million
Table Global Pulmonary Drugs Market Forecast 2019-2025, by Type, in Volume
Table AstraZeneca plc Overview List
Table Pulmonary Drugs Business Operation of AstraZeneca plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer AG Overview List
Table Pulmonary Drugs Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Industries Ltd Overview List
Table Pulmonary Drugs Business Operation of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Actelion Pharmaceuticals, Inc. Overview List
Table Pulmonary Drugs Business Operation of Actelion Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim GmbH Overview List
Table Pulmonary Drugs Business Operation of Boehringer Ingelheim GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table F. Hoffmann-La Roche Ltd. Overview List
Table Pulmonary Drugs Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co., Inc. Overview List
Table Pulmonary Drugs Business Operation of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis AG Overview List
Table Pulmonary Drugs Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline plc Overview List
Table Pulmonary Drugs Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sunovion Pharmaceuticals Overview List
Table Pulmonary Drugs Business Operation of Sunovion Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

List Of Figures

LIST OF FIGURES

Figure Global Pulmonary Drugs Market Growth 2015-2018, by Type, in USD Million
Figure Global Pulmonary Drugs Market Growth 2015-2018, by Type, in Volume